EBOS welcomes finalisation of 7th CPA

EBOS Group Ltd│ NZBN 9429031998840│
Level 7, 737 Bourke Street, Docklands, Victoria 3008, Australia | PO Box 7300, Melbourne, Victoria 3004, Australia |
Phone: +61 3 9918 5555 │ Fax: +61 3 9918 5599│

www.ebosgroup.com



16 June 2020


NZX/ASX Code: EBO


EBOS welcomes finalisation of 7
th
Community Pharmacy Agreement


EBOS Group Limited (“EBOS”) is pleased to announce that a mutually beneficial outcome with the Federal
Government has been achieved following the recent execution of the 7
th
Community Pharmacy Agreement (“CPA”
or the “Agreement”).

EBOS, through its market leading national healthcare wholesaler and wholly-owned subsidiary Symbion, together
with members of the National Pharmaceutical Services Association (NPSA), has been actively engaged in
negotiations with the Department of Health and Federal Minister for Health, The Honourable Greg Hunt MP, with
respect to a successful outcome for the 7
th
CPA.

EBOS Group Chief Executive Officer John Cullity said the Agreement provided the long term certainty the company
and other NPSA members need to ensure all Australians have timely access to all important medicines wherever
they live. The NPSA members are part of the national network of Community Service Obligation (CSO) wholesale
distributors that support the delivery of medicines to all Australians through our community pharmacy partners.

“In announcing the Agreement the Minister for Health has recognised the importance of the wholesale model in
supporting community pharmacies in providing equitable and timely access to medicines for all Australians,
particularly those living outside our major cities”, he said.

“We operate in a highly competitive and regulated market and our position throughout these negotiations was
that in order for Symbion to maintain its service standards then support through a sustainable wholesale
remuneration model was necessary.

“We are therefore pleased that, through this Agreement, the Government has recognised both the vital role of
retail pharmacy in meeting the community’s health needs as well as the critical role all CSO wholesalers play in
ensuring the timely distribution of medicines across Australia”.

The new arrangements provide CSO wholesale distributors with an additional $92 million investment into the CSO
funding pool, and introduction of a restructured wholesale mark-up for PBS medicines, to continue to support
medicine supply through the wholesaler network over the next five years.

Mr Cullity also praised the Department of Health and Minister Hunt for their positive engagement during
negotiations and for acknowledging the role Symbion plays as part of Australia’s critical infrastructure.

“The recent devastating bushfires and the ongoing COVID-19 pandemic have highlighted the critical role we play in
ensuring Australians can continue to access critical medicines, particularly in rural areas, even under the most
extraordinary and difficult circumstances,” he said.

EBOS Group Ltd│ NZBN 9429031998840│
Level 7, 737 Bourke Street, Docklands, Victoria 3008, Australia | PO Box 7300, Melbourne, Victoria 3004, Australia |
Phone: +61 3 9918 5555 │ Fax: +61 3 9918 5599│

www.ebosgroup.com





“Importantly, these crises have highlighted the value of the strong and collaborative relationship we have
developed with the Minister and the Department, which has seen us work together pro-actively to ensure the CSO
model continues to deliver equitable access to medicines for all Australians.”




Authorised for lodgement with NZX and ASX by:

John Cullity
Chief Executive Officer
EBOS Group Limited


For further information, please contact:

Media: Investor Relations:

New Zealand Martin Krauskopf
Geoff Senescall General Manager, M&A and Investor Relations
Senescall Akers EBOS Group Limited
+64 21 481 234 +61 402 026 060

Australia
James Aanensen
PRX
+61 410 518 590


About EBOS Group

EBOS Group Limited is the largest and most diversified Australasian marketer, wholesaler and distributor of
healthcare, medical and pharmaceutical products. It is also a leading marketer and distributor of recognised
consumer products and animal care brands.